Clinical Features and Prognosis of Spontaneous Bacterial Peritonitis in Korean Patients with Liver Cirrhosis: A Multicenter Retrospective Study

키워드

참고문헌 (46)

1. Runyon BA, "Spontaneous bacterial peritonitis: an explosion of information", Hepatology, 8, pp.171~175 (1988)
2. Such J, "Spontaneous bacterial peritonitis", Clin Infect Dis, 27, pp.669~674 (1998)
3. Fernandez J, "Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis", Hepatology, 35, pp.140~148 (2002)
4. Pinzello G, "Spontaneous bacterial peritonitis: a prospective investigation in predominantly nonalcoholic cirrhotic patients", Hepatology, 3, pp.545~549 (1983)
5. Cirera I, "Bacterial translocation of enteric organisms in patients with cirrhosis", J Hepatol, 34, pp.32~37 (2001)
6. Berg RD, "Bacterial translocation from the gastrointestinal tract", Adv Exp Med Biol, 473, pp.11~30 (1999)
7. Guarner C, "Bacterial translocation and its consequences in patients with cirrhosis", Eur J Gastroenterol Hepatol, 17, pp.27~31 (2005)
8. Wiest R, "Bacterial translocation (BT) in cirrhosis", Hepatology, 41, pp.422~433 (2005)
9. Runyon BA, "Early events in spontaneous bacterial peritonitis", Gut, 53, pp.782~784 (2004)
10. De Fernandez MA, "Neutrophil phagocytic and bactericidal function in primary biliary cirrhosis and other chronic liver diseases", Clin Exp Immunol, 67, pp.655~661 (1987)
11. Fiuza C, "Granulocyte colony-stimulating factor improves deficient in vitro neutrophil transendothelial migration in patients with advanced liver disease", Clin Diagn Lab Immunol, 9, pp.433~439 (2002)
12. Runyon BA, "Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis", Gastroenterology, 91, pp.1343~1346 (1986)
13. Tito L, "Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors", Hepatology, 8, pp.27~31 (1988)
14. Guarner C, "Risk of a first community- acquired spontaneous bacterial peritonitis in cirrhotics with low ascitic fluid protein levels", Gastroenterology, 117, pp.414~419 (1999)
15. Kerr DN, "Infection of ascitic fluid in patients with hepatic cirrhosis", Gut, 4, pp.394~398 (1963)
16. Conn HO, "Spontaneous peritonitis and bacteremia in Laennec's cirrhosis caused by enteric organisms: a relatively common but rarely recognized syndrome", Ann Intern Med, 60, pp.568~580 (1964)
17. Felisart J, "Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections", Hepatology, 5, pp.457~462 (1985)
18. Toledo C, "Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime", Hepatology, 17, pp.251~257 (1993)
19. Llovet JM, "Short-term prognosis of cirrhotics with spontaneous bacterial peritonitis: multivariate study", Am J Gastroenterol, 88, pp.388~392 (1993)
20. Follo A, "Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis", Hepatology, 20, pp.1495~1501 (1994)
21. Rimola A, "Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study", Hepatology, 21, pp.674~679 (1995)
22. Sort P, "Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis", N Engl J Med, 341, pp.403~409 (1999)
23. Gines P, "Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial", Hepatology, 12, pp.716~724 (1990)
24. Rolachon A, "Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: results of a prospective controlled trial", Hepatology, 22, pp.1171~1174 (1995)
25. Terg R, "Effects of oral ciprofloxacin on aerobic gram-negative fecal flora in patients with cirrhosis: results of short- and long-term administration, with daily and weekly dosages", J Hepatol, 29, pp.437~442 (1998)
26. Singh N, "Trimethoprim- sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial", Ann Intern Med, 122, pp.595~598 (1995)
27. Dupeyron C, "Rapid emergence of quinolone resistance in cirrhotic patients treated with norfloxacin to prevent spontaneous bacterial peritonitis", Antimicrob Agents Chemother, 38, pp.340~344 (1994)
28. Yamaguchi K, "Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in Japan. in: Japan Antimicrobial Resistance Study Group", Diagn Microbiol Infect Dis, 34, pp.123~134 (1999)
29. Jones RN, "Epidemiologic trends in nosocomial and community-acquired infections due to antibiotic- resistant gram-positive bacteria: the role of streptogramins and other newer compounds", Diagn Microbiol Infect Dis, 33, pp.101~112 (1999)
30. Goossens H, "European status of resistance in nosocomial infections", Chemotherapy, 51, pp.177~181 (2005)
31. Park YH, "Recent increase in antibiotic- resistant microorganisms in patients with spontaneous bacterial peritonitis adversely affects the clinical outcome in Korea", J Gastroenterol Hepatol, 18, pp.927~933 (2003)
32. Guarner C, "Spontaneous bacterial peritonitis", Semin Liver Dis, 17, pp.203~217 (1997)
33. Akriviadis EA, "Utility of an algorithm in differentiating spontaneous from secondary bacterial peritonitis", Gastroenterology, 98, pp.127~133 (1990)
34. Aparicio JR, "Development of quinolone- resistant strains of Escherichia coli in stools of patients with cirrhosis undergoing norfloxacin prophylaxis: clinical consequences", J Hepatol, 31, pp.277~283 (1999)
35. Runyon BA, "Optimization of ascitic fluid culture technique", Gastroenterology, 95, pp.1351~1355 (1988)
36. National Commettee for Clinical Laboratory Standards, "Performance standard for antimicrobial disk susceptibility test: approved standard M2-A6. Vallanova: National Committee for Clinical Laboratory Standars", ~ (1997)
37. Kamath PS, "A model to predict survival in patients with end-stage liver disease", Hepatology, 33, pp.464~470 (2001)
38. Ricart E, "Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients", J Hepatol, 32, pp.596~602 (2000)
39. Correia JP, "Spontaneous bacterial peritonitis in cirrhosis: endemic or epidemic?", Med Clin North Am, 59, pp.963~981 (1975)
40. Runyon BA, "Culture-negative neutrocytic ascites: a variant of spontaneous bacterial peritonitis", Hepatology, 4, pp.1209~1211 (1984)
41. Cho JH, "Bacteremia is a prognostic factor for poor outcome in spontaneous bacterial peritonitis", Scand J Infect Dis, 39, pp.697~702 (2007)
42. Cholongitas E, "Increasing frequency of Gram-positive bacteria in spontaneous bacterial peritonitis", Liver Int, 25, pp.57~61 (2005)
43. Evans LT, "Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites", Hepatology, 37, pp.897~901 (2003)
44. Grange JD, "Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial", J Hepatol, 29, pp.430~436 (1998)
45. Novella M, "Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin", Hepatology, 25, pp.532~536 (1997)
46. Runyon BA, "Management of adult patients with ascites due to cirrhosis", Hepatology, 39, pp.841~856 (2004)

관련 논문AI추천